Literature DB >> 24713476

Use of dried blood spots in doping control analysis of anabolic steroid esters.

Laura Tretzel1, Andreas Thomas1, Hans Geyer1, Günter Gmeiner2, Guro Forsdahl2, Valentin Pop3, Wilhelm Schänzer1, Mario Thevis4.   

Abstract

Dried blood spot (DBS) sampling, a technique for whole blood sampling on a piece of filter paper, has more than 50-years tradition, particularly in the diagnostic analysis of metabolic disorders in neonatal screening. Due to the minimal invasiveness, straightforwardness, robustness against manipulation and fastness DBS sampling recommends itself as an advantageous technique in doping control analysis. The present approach highlights the development of a screening assay for the analysis of eight anabolic steroid esters (nandrolone phenylpropionate, trenbolone enanthate, testosterone acetate, testosterone cypionate, testosterone isocaproate, testosterone phenylpropionate, testosterone decanoate and testosterone undecanoate) and nandrolone in DBS. The detection of the intact esters allows an unequivocal proof of the administration of conjugates of exogenous testosterone and its derivatives. Precise, specific and linear conditions were obtained by means of liquid chromatography high resolution/high accuracy mass spectrometry. Sensitivity in the low ppb range was accomplished by the preparation of the methyloxime derivatives of the target compounds. Labeled internal standards (d3-nandrolone, d3-nandrolone caproate and d3-nandrolone undecanoate) were applied to compensate for the broad range in chain length of the esters. The assay presented here outlines the application of DBS for the analysis of anabolic steroid esters in doping controls for the first time providing great potential to simplify the proof of exogenous administration of testosterone.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anabolic steroid ester; Doping control analysis; Dried blood spots; LC–MS/MS; Mass spectrometry; Testosterone

Mesh:

Substances:

Year:  2014        PMID: 24713476     DOI: 10.1016/j.jpba.2014.03.013

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

Authors:  Mario Thevis; Oliver Krug; Hans Geyer; Wilhelm Schänzer
Journal:  Rapid Commun Mass Spectrom       Date:  2017-08-15       Impact factor: 2.419

2.  Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process.

Authors:  Rosita Zakaria; Katrina J Allen; Jennifer J Koplin; Peter Roche; Ronda F Greaves
Journal:  EJIFCC       Date:  2016-12-01

3.  Analysis of the Heterogeneous Distribution of Amiloride and Propranolol in Dried Blood Spot by UHPLC-FLD and MALDI-IMS.

Authors:  Beatriz Uribe; Oskar González; María Encarnación Blanco; Oihane Elena Albóniga; María Luz Alonso; Rosa María Alonso
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

4.  UHPLC-HRMS Method for the Simultaneous Screening of 235 Drugs in Capillary Blood for Doping Control Purpose: Comparative Evaluation of Volumetric and Non-volumetric Dried Blood Spotting Devices.

Authors:  Monica Mazzarino; Ludovica Di Costanzo; Fabio Comunità; Carlotta Stacchini; Xavier de la Torre; Francesco Botrè
Journal:  ACS Omega       Date:  2022-08-29

5.  A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases.

Authors:  F Boemer; C Fasquelle; S d'Otreppe; C Josse; V Dideberg; K Segers; V Guissard; V Capraro; F G Debray; V Bours
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

6.  Virtual drug testing: redefining sample collection in a global pandemic.

Authors:  Matthew N Fedoruk
Journal:  Bioanalysis       Date:  2020-06-12       Impact factor: 2.681

7.  Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti-doping application.

Authors:  Carmel E Heiland; Magnus Ericsson; Anton Pohanka; Lena Ekström; Alexandre Marchand
Journal:  Drug Test Anal       Date:  2022-03-30       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.